Lymphoma News
May 5, 2015

Latest Headlines
updated 11:52am EDT

More Lymphoma News
May 5, 2015

New Assay Helps Determine Lymphoma Subtypes Simply, Quickly, and Inexpensively

Apr. 16, 2015 — With the advent of targeted lymphoma therapies on the horizon, it becomes increasingly important to differentiate the two major subtypes of diffuse large B-cell lymphoma (DLBCL), which is the most ... read more

Targeted Drug Doubles Progression Free Survival in Hodgkin Lymphoma

Mar. 19, 2015 — A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell ... read more

Spherical Nucleic Acids Set Stage for New Paradigm in Drug Development

Mar. 16, 2015 — Spherical nucleic acids (SNAs) can be used as potent drugs to effectively train the immune system to fight disease, by either boosting or dampening the immune response. By increasing the immune ... read more

Genetically Engineered Immunotoxin Shows Early Promise in Patients With B-Cell Malignancies

Mar. 13, 2015 — DT2219, a new bispecific ligand-directed diphtheria toxin, was found to be safe and clinically effective in a small group of patients with relapsed/refractory B-cell malignancies, according to phase ... read more

Mar. 12, 2015 — A new genome editing technology has been developed that can target and kill blood cancer cells with high accuracy. Using the technology, researchers were able to kill human lymphoma cells by locating ... read more

Childhood Leukemia Study Reveals Disease Subtypes, New Treatment Option

Mar. 9, 2015 — A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence ... read more

Treatment Guidelines for Pediatric Hodgkin Lymphoma Outlined

Mar. 4, 2015 — A guideline has been issued that outlines the use of 3-D computed tomography (CT)-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma ... read more

Jan. 26, 2015 — Scientists have revealed how a type of cancer-causing virus outwits the human body's immune response. The discovery might help explain why some cancer therapies that incorporate interferon fail ... read more

Jan. 12, 2015 — Targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies, researchers have ... read more

Added Benefit of Idelalisib Is Not Proven

Jan. 8, 2015 — The drug manufacturer presented no suitable data to evaluators for the therapeutic indication chronic lymphocytic leukaemia or for refractory follicular ... read more

Dec. 18, 2014 — Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor ... read more

Effectiveness of Drugs to Prevent Hepatitis Among Patients Receiving Chemotherapy

Dec. 16, 2014 — Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV ... read more

Cancer Therapy Using Specialized Apheresis Holds Great Promise

Dec. 11, 2014 — Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists. In the case of ECP, investigators' ... read more

Immunotherapy Shows Clinical Benefit in Relapsed Transplant Recipients

Dec. 9, 2014 — A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation, ... read more

Advances in Lymphoma and Multiple Myeloma Treatment Seek to Improve Outcomes for Patients

Dec. 8, 2014 — New treatment combinations and targeted therapies for lymphoma and multiple myeloma are improving outcomes for vulnerable patient populations with hard-to-treat disease, according to new ... read more

Immunotherapy Achieves Breakthrough Result in Patients With Hodgkin Lymphoma

Dec. 7, 2014 — Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission, scientists report. The results provide some of the most ... read more

Positive Data from Pivotal Phase III Study Could Improve Standard of Care for Hodgkin Lymphoma Patients

Dec. 7, 2014 — In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care, ... read more

Immunotherapy Drugs Improve Outcomes in Hodgkin Lymphoma Patients, Study Shows

Dec. 7, 2014 — In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma ... read more

Early Results Show Response to New Drug in Patients With Lymphomas, Advanced Solid Tumours

Nov. 19, 2014 — Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical ... read more

Nov. 17, 2014 — The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma). A ... read more

Thursday, April 16, 2015
Thursday, March 19, 2015
Monday, March 16, 2015
Friday, March 13, 2015
Thursday, March 12, 2015
Monday, March 9, 2015
Wednesday, March 4, 2015
Monday, January 26, 2015
Monday, January 12, 2015
Thursday, January 8, 2015
Thursday, December 18, 2014
Tuesday, December 16, 2014
Thursday, December 11, 2014
Tuesday, December 9, 2014
Monday, December 8, 2014
Sunday, December 7, 2014
Wednesday, November 19, 2014
Monday, November 17, 2014
Wednesday, November 5, 2014
Wednesday, October 22, 2014
Sunday, October 19, 2014
Monday, October 6, 2014
Wednesday, September 17, 2014
Tuesday, September 9, 2014
Monday, August 25, 2014
Friday, August 22, 2014
Tuesday, August 19, 2014
Monday, August 4, 2014
Sunday, July 27, 2014
Monday, July 14, 2014
Monday, July 7, 2014
Monday, June 30, 2014
Thursday, June 26, 2014
Thursday, June 19, 2014
Monday, June 9, 2014
Friday, May 30, 2014
Wednesday, May 28, 2014
Sunday, May 25, 2014
Friday, May 23, 2014
Thursday, May 8, 2014
Tuesday, April 29, 2014
Thursday, April 10, 2014
Tuesday, April 8, 2014
Monday, April 7, 2014
Thursday, March 20, 2014
Wednesday, March 19, 2014
Monday, March 10, 2014
Tuesday, February 25, 2014
Monday, February 17, 2014
Thursday, February 13, 2014
Friday, January 31, 2014
Thursday, January 23, 2014
Tuesday, January 14, 2014
Tuesday, January 7, 2014
Thursday, December 19, 2013
Wednesday, December 18, 2013
Wednesday, December 11, 2013
Tuesday, December 10, 2013
Friday, November 22, 2013
Wednesday, November 13, 2013
Wednesday, October 30, 2013
Monday, October 14, 2013
Saturday, October 12, 2013
Wednesday, October 2, 2013
Tuesday, August 27, 2013
Wednesday, August 21, 2013
Friday, August 16, 2013
Thursday, August 8, 2013
Monday, August 5, 2013
Thursday, August 1, 2013
Monday, July 29, 2013
Sunday, July 28, 2013
Tuesday, July 16, 2013
Tuesday, June 25, 2013
Thursday, May 30, 2013
Tuesday, May 21, 2013
Monday, May 13, 2013
Tuesday, April 16, 2013
Sunday, April 7, 2013
Tuesday, April 2, 2013
Monday, April 1, 2013
Wednesday, March 13, 2013
Sunday, March 3, 2013
Thursday, February 21, 2013
Wednesday, February 6, 2013
Monday, February 4, 2013
Thursday, January 24, 2013
Monday, January 21, 2013